Einfluss der Adipositas in der Urogynäkologie

Zusammenfassung

Beckenbodenfunktionsstörungen wie Genitaldeszensus, Belastungsinkontinenz, überaktive Blase und Stuhlinkontinenz zählen zu den häufigsten urogynäkologischen Krankheitsbildern. Die postmenopausale Prävalenz liegt bei ca. 40%. Hauptursachen sind Geburten, fortschreitendes Alter und Hormonmangel in der Menopause. Chronischer Druck auf den Beckenboden durch Übergewicht und Adipositas, oft in Verbindung mit Diabetes mellitus, sind weitere Risikofaktoren. Studien zeigen, dass Übergewicht die Häufigkeit von Beckenbodenfunktionsstörungen erhöht, wobei ein höherer BMI mit einer höheren Prävalenz von Harn- und Stuhlinkontinenz sowie Genitaldeszensus korreliert. Eine Gewichtsabnahme kann die urogynäkologischen Symptome verbessern, bei 5–10% Gewichtsreduktion wird ein Rückgang der Inkontinenzepisoden bis zu 60% beschrieben. Jedoch sind die langfristigen Erfolge oft begrenzt. Hier stellen die medikamentöse Therapie der Adipositas und die bariatrische Chirurgie eine Therapieoption dar. Daher sollte die Beratung adipöser Frauen nicht nur die möglichen urogynäkologischen Folgen thematisieren, sondern auch gezielt zur Gewichtsreduktion motivieren. Bei Schwangeren kann Übergewicht das Risiko für postpartale Beckenbodenstörungen deutlich erhöhen. Daher sind prä- und postpartale Maßnahmen zur Beckenbodengesundheit besonders wichtig.

Abstract

Pelvic floor dysfunction such as genital prolapse, stress incontinence, overactive bladder and fecal incontinence are among the most common urogynecological diseases. The postmenopausal prevalence is around 40%. The main causes are childbirth, advancing age and hormone deficiency during menopause. Chronic pressure on the pelvic floor caused by overweight and obesity, often associated with diabetes mellitus, are further risk factors. Studies show that obesity increases the incidence of pelvic floor dysfunction, with higher BMI correlating with a higher prevalence of urinary and fecal incontinence and genital prolapse. Losing weight can improve urogynecological symptoms; with 5–10% weight loss, a reduction in incontinence episodes of up to 60% has been described. However, long-term success is often limited. Here, drug therapy for obesity and bariatric surgery represent a treatment option. Therefore, counseling for obese women should not only address the possible urogynecological consequences, but also specifically motivate them to lose weight. In pregnant women, being overweight can significantly increase the risk of postpartum pelvic floor disorders. Therefore, pre- and postpartum measures for pelvic floor health are particularly important.

Schlüsselwörter

Urogynäkologie - Genitaldeszensus - Inkontinenz - Adipositas

Keywords

urogynaecology - genital prolapse - incontinence - obesity

Publikationsverlauf

Artikel online veröffentlicht:
13. Dezember 2024

• Literatur

• 1 Jundt K, Peschers U, Kentenich H. The investigation and treatment of female pelvic floor dysfunction. Dtsch Arztebl Int 2015; 112: 564-574
• 2 Probst M, Pages H, Riemann JF. et al. Fecal Incontinence — Part 4 of a Series of Articles on Incontinence. Dtsch Arztebl Int 2010; 107: 596-601
• 3 Nygaard I, Barber MD, Burgio KL. et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300: 1311-1316
• 4 Robert Koch-Institut 2021. Studie GEDA 2019/2020-EHIS
• 5 Chen CC, Gatmaitan P, Koepp S. et al. Obesity is associated with increased prevalence and severity of pelvic floor disorders in women considering bariatric surgery. Surg Obes Relat Dis 2009; 5: 411-415
• 6 Richter HE, Burgio KL, Clements RH. et al. Urinary and anal incontinence in morbidly obese women considering weight loss surgery. Obstet Gynecol 2005; 106: 1272-1277
• 7 Kuhn A. Rechtzeitig zu den Festtagen: Adipositas und Beckenboden. Frauenheilkunde aktuell 2014; 04: 4-7
• 8 Smith FJ, Holman CDJ, Moorin RE. et al. Lifetime risk of undergoing surgery for pelvic organ prolapse. Obstet Gynecol 2010; 116: 1096-1100
• 9 Washington BB, Erekson EA, Kassis NC. et al. The association between obesity and stage II or greater prolapse. Am J Obstet Gynecol 2010; 202: 503e1-504e1
• 10 Hendrix S. Pelvic organ prolapse in the women’s health initiative: gravity and gravidity. Am J Obstet Gynecol 2002; 186: 1160-1166
• 11 Kudish BI, Iglesia CB, Sokol RJ. et al. Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol 2009; 113: 81-88
• 12 Bradley CS, Kenton KS, Richter HE. et al. Obesity and out comes after sacrocolpopexy. Am J Obstet Gynecol 2008; 199: 690e1-698e1
• 13 Ogrinc UB, Sencar S, Lenasi H. Novel minimally invasive laser treatment of urinary incontinence in women. Lasers Surg Med 2015; 47: 689-697
• 14 Female Urinary Incontinence. Guideline of the DGG, OEGGG and SGGG. 2sk-Level, AWMF Registry No.015-091, December 2021
• 15 Subak LL, Wing R, West DS. et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360: 481-490
• 16 Hunskaar S. A systematic review of overweight and obesity as risk factors and targets for clinical intervention for urinary incontinence in women. Neurourol Urodyn 2008; 27: 749-757
• 17 Brown JS. Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol 1999; 94: 66-70
• 18 Richter HE, Burgio KL, Clements RH. et al. Urinary and anal incontinence in morbidly obese women considering weight loss surgery. Obstet Gynecol 2005; 106: 1272-1277
• 19 Wasserberg N, Petrone P, Haney M. et al. Effect of surgically induced weight loss on pelvic floor disorders in morbidly obese women. Ann Surg 2009; 249: 72-76
• 20 Burgio KL, Richter HE, Clements RH. et al. Changes in urinary and fecal incontinence symptoms with weight loss surgery in morbidly obese women. Obstet Gynecol 2007; 110: 1034-1040
• 21 Brown JS, Seeley DG, Fong J. et al. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol 1996; 87: 715-721
• 22 Thubert T, Deffieux X, Letouzey V. et al. Obésité et urogynécologie: revue de la literature. Obesity and urogynecology: A systematic review. Progrès en Urologie 2012; 22: 445-453
• 23 Subak LL, Whitcomb E, Shen H. et al. Weight loss: a novel and effective treatment for urinary incontinence. J Urol 2005; 174: 190-195
• 24 Subak LL, Wing R, West DS. et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med 2009; 360: 481-490
• 25 Gozukara YM, Akalan G, Tok EC. et al. The improvement in pelvic floor symptoms with weight loss in obese women does not correlate with the changes in pelvic anatomy. Int Urogynecol J 2014; 25: 1219-1225
• 26 Larsson UE. Influence of weight loss on pain, perceived disabi lity and observed functional limitations in obese women. Int J Obes Relat Metab Disord 2004; 28: 269-277
• 27 Greer WJ, Richter HE, Bartolucci AA. et al. Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol 2008; 112: 341-349
• 28 Lovatsis D, Gupta C, Dean E. et al. Tension-free vaginal tape procedure is an ideal treatment for obese patients. Am J Obstet Gynecol 2003; 189: 1601-1605
• 29 Skriapas K, Poulakis V, Dillenburg W. et al. Tension-free vaginal tape (TVT) in morbidly obese patients with severe urodynamic stress incontinence as last option treatment. Eur Urol 2006; 49: 544-550
• 30 Rafii A, Darai E, Haab F. et al. Body mass index and outcome of tension-free vaginal tape. Eur Urol 2003; 43: 288-292
• 31 Greer WJ, Richter HE, Bartolucci AA. et al. Obesity and pelvic floor disorders: a systematic review. Obstet Gynecol 2008; 112: 341-349
• 32 Hellberg D, Holmgren C, Lanner L. et al. The very obese woman and the very old woman: tension free vaginal tape for the treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2007; 18: 423-429
• 33 Bandarian M, Ghanbari Z, Asgari A. Comparison of transobtura tor tape (TOT) vs. Burch method in treatment of stress urinary incontinence. J Obstet Gynaecol 2011; 31: 518-520
• 34 Viecelli CF, dos Santos DCS, Aguiar WWS. et al. Obesity as a risk factor to Burch surgery failure. Rev Bras Ginecol Obstet 2009; 31: 182-188
• 35 Poylin V, Serrot FJ, Madoff RD. et al. Obesity and bariatric surgery: a systematic review of associations with defecatory dysfunction. Colorectal Dis 2011; 13: e92-e103
• 36 Erekson EA, Sung VW, Myers DL. Effect of body mass index on the risk of anal incontinence and defecatory dysfunction in women. Am J Obst Gynecol 2008; 198: 596e1-4
• 37 Bump RC, Sugerman HJ, Fantl JA. et al. Obesity and lower urinary tract function in women: effect of surgically induced weight loss. Am J Obstet Gynecol 1992; 167: 392-397
• 38 Deitel M, Stone E, Kassam HA. et al. Gynecologic–obstetric changes after loss of massive excess weight following bariatric surgery. J Am Coll Nutr 1988; 7: 147-153
• 39 Jastreboff AM, Aronne LJ, Ahmad NN. et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med 2022; 387: 205-216
• 40 Metz M, Junginger B, Henrich W. et al. Development and Validation of a Questionnaire for the Assessment of Pelvic Floor Disorders and Their Risk Factors During Pregnancy and Post Partum. GebFra 2017; 77: 358-365
• 41 Gabriel B, Reisenauer C. Geburtshilfe und Beckenboden – diese Risiken erhöhen Funktionsstörungen. DGGG. 2020